Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Our name, Alumis, captures our
mission to enlighten immunology, and is inspired by the words "allumer"-French for illuminate-and "immunis"-Latin for the immune system.
Lead Underwriter
Cantor Fitzgerald & Co.Guggenheim Securities, LLC,Leerink Partners LLC,Morgan Stanley & Co. LLC
